Study Indicates Web-Based Tools Can Aid in the Prevention of Major Depressive Disorder | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Study Indicates Web-Based Tools Can Aid in the Prevention of Major Depressive Disorder

May 5, 2016
by Heather Landi
| Reprints
Click To View Gallery

There has been ongoing research and discussion about the use of digital health tools in the treatment of mental health disorders, and also in the prevention of more severe symptoms of those disorders. One study conducted by researchers in Germany and the Netherlands, and published in the Journal of the American Medical Association (JAMA), showed promising results for the use of web-based, guided self-help intervention for the prevention of major depressive disorder (MDD).

According to the researchers, evidence-based treatments for MDD are not very successful in improving functional and health outcomes, and attention has increasingly been focused on the prevention of MDD.

For the study, researchers conducted a randomized clinical trial from March 2013 through March 2015 involved 406 adults with subthreshold depression, or those adults with a Centre for Epidemiologic Studies Depression Scale score greater than or at 16 and no current MDD according to the Diagnostic and Statistical Manual of Mental Disorders.

Study participants were divided into two groups, with both groups having access to usual care, such as visits to a primary care clinician. However, one group also had access to a web-based guided self-help intervention, which involved cognitive-behavioral and problem-solving therapy supported by an online trainer.

The researchers wanted to examine the time to onset of MDD in the intervention group relative to the control group over a 12-month follow-up period.

The results of the 12-month follow-up indicated that 27 percent of the study participants in the intervention group experienced major depressive disorder symptoms compared to 41 percent in the control group.

The researchers concluded that among patients with subthreshold depression, “the use of web-based guided self-help intervention compared with enhanced usual care reduced the incidence of MDD over 12 months.”

However, the researchers also noted that further research is need to examine “whether the effects are generalizable to both first onset of depression and depression recurrence as well as efficacy without the use of an online trainer.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Cedars-Sinai Collaborates on Organs-on-Chip Precision Medicine Project

Scientists at Los Angeles-based Cedars-Sinai, in partnership with biotechnology startup Emulate, are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant.

Blockchain Company Hashed Health Gets New Partner

ODH, Inc., a New Jersey-based health technology company, has joined with blockchain innovation consortium Hashed Health.

NCQA Approved by Government as ONC-Authorized Testing Lab

The National Committee for Quality Assurance (NCQA) has announced that its eMeasure testing laboratory is now approved by the Office of the National Coordinator for Health Information Technology (ONC).

Survey: Infrastructure, Interoperability Key Barriers to Global HIT Development

A new survey report from Black Book Research on global healthcare IT adoption and records systems connectivity finds nations in various phases of regional electronic health record (EHR) adoption. The survey results also reveal rapidly advancing opportunities for U.S.-based and local technology vendors.

Penn Medicine Opens Up Telehealth Hub

Philadelphia-based Penn Medicine has opened its Center for Connected Care to centralize the health system’s telemedicine activities.

Roche to Pay $1.9B for Flatiron Health

Switzerland-based pharmaceutical company Roche has agreed to pay $1.9 billion to buy New York-based Flatiron Health Inc., which has both an oncology EHR and data analytics platform.